Genistein Prevents Development of Spontaneous Ovarian Cancer and Inhibits Tumor Growth in Hen Model.


Journal

Cancer prevention research (Philadelphia, Pa.)
ISSN: 1940-6215
Titre abrégé: Cancer Prev Res (Phila)
Pays: United States
ID NLM: 101479409

Informations de publication

Date de publication:
03 2019
Historique:
received: 08 09 2017
revised: 30 07 2018
accepted: 10 01 2019
pubmed: 18 1 2019
medline: 10 6 2020
entrez: 18 1 2019
Statut: ppublish

Résumé

Genistein, the major isoflavone in soybean, has been reported to exert anticancer effects on various types of cancer including ovarian cancer; however, its chemopreventive effects and mechanisms of action in ovarian cancer have not been fully elucidated in spontaneously developing ovarian cancer models. In this study, we demonstrated the preventive effects and mechanisms of genistein in the laying hen model that develops spontaneous ovarian cancer at high incidence rates. Laying hens were randomized to three groups: control (3.01 mg/hen,

Identifiants

pubmed: 30651293
pii: 1940-6207.CAPR-17-0289
doi: 10.1158/1940-6207.CAPR-17-0289
doi:

Substances chimiques

Anticarcinogenic Agents 0
Genistein DH2M523P0H

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-146

Informations de copyright

©2019 American Association for Cancer Research.

Auteurs

Kazim Sahin (K)

Department of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig, Turkey.

Engin Yenice (E)

Poultry Research Institute, Ankara, Turkey.

Birdal Bilir (B)

Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia.

Cemal Orhan (C)

Department of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig, Turkey.

Mehmet Tuzcu (M)

Division of Biology, Faculty of Science, Firat University, Elazig, Turkey.

Nurhan Sahin (N)

Department of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig, Turkey.

Ibrahim H Ozercan (IH)

Department of Pathology, Faculty of Medicine, Firat University, Elazig, Turkey.

Nashwa Kabil (N)

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Bulent Ozpolat (B)

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. bozpolat@mdanderson.org.
Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Omer Kucuk (O)

Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia. bozpolat@mdanderson.org.
Winship Cancer Institute, Emory University, Atlanta, Georgia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH